Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 8:50 pm Sale | 2026-02-10 | 13G | ERNEXA THERAPEUTICS INC P ERNA | John D. Halpern | 66,751 5.600% | -331,371 (-83.23%) | Filing History |
| 2025-05-15 9:13 pm Purchase | 2025-03-31 | 13G | ERNEXA THERAPEUTICS INC ERNA | John D. Halpern | 15,925 9.600% | 2,227 (+16.26%) | Filing History |
| 2025-02-14 8:36 pm Purchase | 2024-10-29 | 13G | ERNEXA THERAPEUTICS INC ERNA | John D. Halpern | 13,698 9.990% | 12,229 (+832.47%) | Filing History |
| 2024-01-31 07:05 am Purchase | 2023-12-31 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 550,894 9.990% | 98,611 (+21.80%) | Filing History |
| 2023-01-31 4:05 pm Purchase | 2023-01-31 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 452,283 8.800% | 1,117 (+0.25%) | Filing History |
| 2022-12-05 5:20 pm Sale | 2022-12-02 | 13G | BROOKLYN IMMUNO THERAPEUTICS L ERNAW | John D. Halpern | 451,166 8.800% | -4,296,079 (-90.50%) | Filing History |